In a nutshell This study wanted to find out which treatment for melanoma cancer worked better, encorafenib (Braftovi) + binimetinib (Mektovi), encorafenib alone, or vemurafenib (Zelboraf) alone. The study found that encorafenib + binimetinib worked well and was safe, compared to vemurafenib and encorafenib. Some background In about 50% of patients...
Read More
In a nutshell The authors discussed isolated limb perfusion, a procedure used to deliver high doses of drugs straight to the site of the tumor in patients with melanoma. Some background Melanoma is sensitive to chemotherapy but it needs higher doses of chemotherapy than other types of cancer. Isolated limb perfusion is a complex...
Read More
In a nutshell The aim of this study was to evaluate the usefulness of sentinel lymph node biopsy (SLNB), a diagnostic procedure, in thick melanoma (thickness ≥ 4mm). Some background Melanoma is a type of cancer that starts in color-producing cells of the skin. It can grow deep into the inner layers of skin and spread into lymph nodes (tiny,...
Read More
In a nutshell This study examined how quality of life (QOL) affects survival and the risk of recurrence in high-risk melanoma patients. Some background Maintaining QOL is a crucial goal in the treatment of cancer patients. QOL can be measured in many ways, including specific factors such as appetite and fatigue. QOL also refers to broader terms...
Read More
